Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 4 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 23, 2021 Filed Nov 26, 2021 21:06 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 7,000 | $1.35 | $9,450.00 |
DisclosureSEC source: 0001209191-21-066923 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,953,147 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.33 to $1.39, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 21:05 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 3,500 | $1.32 | $4,620.00 |
DisclosureSEC source: 0001209191-21-066920 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 138,361 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.26 to $1.35, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:08 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 12,000 | $1.44 | $17,280.00 |
DisclosureSEC source: 0001209191-21-066398 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,946,147 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.49, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:27 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 8,900 | $1.44 | $12,816.00 |
DisclosureSEC source: 0001209191-21-066428 · doc4.xml · nonDerivative · entry 5 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 134,861 F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.39 to $1.49, inclusive Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:08 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 15,000 | $1.39 | $20,850.00 |
DisclosureSEC source: 0001209191-21-066398 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,934,147 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.35 to $1.40, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:27 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 5,000 | $1.37 | $6,850.00 |
DisclosureSEC source: 0001209191-21-066428 · doc4.xml · nonDerivative · entry 4 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 125,961 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.40, inclusive. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 22:07 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 13,000 | $1.28 | $16,640.00 |
DisclosureSEC source: 0001209191-21-065867 · doc4.xml · nonDerivative · entry 4 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,919,147 F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.21 to $1.44, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 22:07 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 13,000 | $1.29 | $16,770.00 |
DisclosureSEC source: 0001209191-21-065867 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,906,147 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.20 to $1.30, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| November 17, 2021 Filed Nov 23, 2021 21:27 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.29 | $1,290.00 |
DisclosureSEC source: 0001209191-21-066428 · doc4.xml · nonDerivative · entry 3 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 120,961 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.24 to $1.30, inclusive. Read SEC document |
| November 16, 2021 Filed Nov 19, 2021 22:07 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 5,000 | $1.28 | $6,400.00 |
DisclosureSEC source: 0001209191-21-065867 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,893,147 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.25 to $1.29, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| November 16, 2021 Filed Nov 23, 2021 21:27 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 2,100 | $1.29 | $2,709.00 |
DisclosureSEC source: 0001209191-21-066428 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 119,961 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.24 to $1.29, inclusive. Read SEC document |
| November 15, 2021 Filed Nov 19, 2021 22:07 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,000 | $1.25 | $2,500.00 |
DisclosureSEC source: 0001209191-21-065867 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,888,147 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.22 to $1.29, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3), (4) and (5) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| November 15, 2021 Filed Nov 23, 2021 21:27 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,600 | $1.24 | $1,984.00 |
DisclosureSEC source: 0001209191-21-066428 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 117,861 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.19 to $1.25, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2), (3), (4) and (5) to this Form 4. Read SEC document |
| October 20, 2021 Filed Oct 22, 2021 18:41 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.57 | $1,570.00 |
DisclosureSEC source: 0001209191-21-061341 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,886,147 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 06, 2021 Filed Oct 7, 2021 17:40 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.52 | $1,520.00 |
DisclosureSEC source: 0001209191-21-059887 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,885,147 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.52 to $1.59, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 05, 2021 Filed Oct 7, 2021 17:40 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,000 | $1.66 | $3,320.00 |
DisclosureSEC source: 0001209191-21-059887 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,884,147 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.68, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 21:37 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.64 | $1,640.00 |
DisclosureSEC source: 0001209191-21-058088 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,882,147 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 24, 2021 Filed Sep 27, 2021 22:10 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.70 | $1,700.00 |
DisclosureSEC source: 0001209191-21-057831 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,881,147 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 23, 2021 Filed Sep 27, 2021 22:10 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.69 | $2,535.00 |
DisclosureSEC source: 0001209191-21-057831 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,880,147 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 22, 2021 Filed Sep 23, 2021 23:25 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,582 | $1.73 | $2,736.86 |
DisclosureSEC source: 0001209191-21-057505 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,878,647 F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 21, 2021 Filed Sep 23, 2021 23:25 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,000 | $1.64 | $3,280.00 |
DisclosureSEC source: 0001209191-21-057505 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,877,065 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.62 to $1.73, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 17, 2021 Filed Sep 18, 2021 00:38 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 500 | $1.71 | $855.00 |
DisclosureSEC source: 0001209191-21-056785 · doc4.xml · nonDerivative · entry 3 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 116,261 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.65 to $1.73, inclusive. Read SEC document |
| September 16, 2021 Filed Sep 18, 2021 00:38 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.71 | $1,710.00 |
DisclosureSEC source: 0001209191-21-056785 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 115,761 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.62 to $1.72, inclusive. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:38 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 2,000 | $1.51 | $3,020.00 |
DisclosureSEC source: 0001209191-21-056785 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 114,761 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.46 to $1.66, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4. Read SEC document |
| September 15, 2021 Filed Sep 18, 2021 00:23 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,000 | $1.50 | $3,000.00 |
DisclosureSEC source: 0001209191-21-056769 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,875,065 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 10, 2021 Filed Sep 10, 2021 22:17 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 2,000 | $1.72 | $3,440.00 |
DisclosureSEC source: 0001209191-21-055547 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 112,761 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.67 to $1.77, inclusive. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 22:11 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,500 | $1.67 | $4,175.00 |
DisclosureSEC source: 0001209191-21-055724 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,873,065 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.80, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 08, 2021 Filed Sep 8, 2021 21:59 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.75 | $2,625.00 |
DisclosureSEC source: 0001209191-21-055195 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,870,565 F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 22:17 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 2,000 | $1.70 | $3,400.00 |
DisclosureSEC source: 0001209191-21-055547 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 110,761 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.65 to $1.75, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4. Read SEC document |
| September 03, 2021 Filed Sep 8, 2021 21:59 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.58 | $2,370.00 |
DisclosureSEC source: 0001209191-21-055195 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,869,065 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.60, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 02, 2021 Filed Sep 2, 2021 21:58 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.55 | $1,550.00 |
DisclosureSEC source: 0001209191-21-054540 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,867,565 F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 21:58 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.54 | $2,310.00 |
DisclosureSEC source: 0001209191-21-054540 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,866,565 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.54, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:58 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 7,201 | $1.55 | $11,161.55 |
DisclosureSEC source: 0001209191-21-054540 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,865,065 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.52 to $1.55, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 27, 2021 Filed Aug 27, 2021 21:42 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.54 | $2,310.00 |
DisclosureSEC source: 0001209191-21-053681 · doc4.xml · nonDerivative · entry 3 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,574 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.57, inclusive. Read SEC document |
| August 26, 2021 Filed Aug 26, 2021 21:05 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 6,350 | $1.56 | $9,906.00 |
DisclosureSEC source: 0001209191-21-053503 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,857,864 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.60, inclusive. F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 21:42 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.69 | $1,690.00 |
DisclosureSEC source: 0001209191-21-053681 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,074 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80, inclusive. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 21:05 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 5,350 | $1.53 | $8,185.50 |
DisclosureSEC source: 0001209191-21-053503 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,851,514 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.55, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnote (3) to this Form 4. F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 21:42 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 2,400 | $1.51 | $3,624.00 |
DisclosureSEC source: 0001209191-21-053681 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,074 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.55, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:05 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.48 | $2,220.00 |
DisclosureSEC source: 0001209191-21-053503 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,846,164 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 23, 2021 Filed Aug 23, 2021 21:23 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,000 | $1.45 | $2,900.00 |
DisclosureSEC source: 0001209191-21-052977 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,844,664 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.39 to $1.48, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 21:23 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 4,600 | $1.44 | $6,624.00 |
DisclosureSEC source: 0001209191-21-052977 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,842,664 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.36 to $1.50, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 21:23 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,600 | $1.47 | $3,822.00 |
DisclosureSEC source: 0001209191-21-052977 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,838,064 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 18, 2021 Filed Aug 18, 2021 21:28 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.50 | $1,500.00 |
DisclosureSEC source: 0001209191-21-052284 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,835,464 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 21:28 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,200 | $1.49 | $4,768.00 |
DisclosureSEC source: 0001209191-21-052284 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,834,464 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.48 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2). F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:28 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 500 | $1.55 | $775.00 |
DisclosureSEC source: 0001209191-21-052284 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,831,264 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 13, 2021 Filed Aug 13, 2021 23:53 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,793 | $1.54 | $5,841.22 |
DisclosureSEC source: 0001209191-21-051496 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,830,764 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.55, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 23:53 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,000 | $1.50 | $3,000.00 |
DisclosureSEC source: 0001209191-21-051496 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,826,971 F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 11, 2021 Filed Aug 13, 2021 23:53 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,800 | $1.53 | $2,754.00 |
DisclosureSEC source: 0001209191-21-051496 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,824,971 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.55, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 21:25 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,200 | $1.50 | $1,800.00 |
DisclosureSEC source: 0001209191-21-050650 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,823,171 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.48 to $1.50, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:25 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,900 | $1.53 | $5,967.00 |
DisclosureSEC source: 0001209191-21-050650 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,821,971 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.55, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.